As of April 2026, the FDA formally proposed - in a Federal Register notice - removing semaglutide, tirzepatide, and liraglutide from the 503B outsourcing bulks list
Other patients may have medical contraindications, limited insurance coverage, high out-of-pocket costs, difficulty following daily pill instructions, or discomfort with self-injection
I didn't find them to be tastier than the others, though, and enjoyed some of the more basic offerings (which tasted anything but) better
It can only be accessed through approved clinical trials registered with the MHRA
The findings add to a growing body of research suggesting that GLP-1 medications can remain effective throughout the menopause transition
Diabetes Care 41 , e133e135 (2018)